$SYRA Balance Sheet | Understand Stock

$SYRA

$0.93 +$0.01 (0.98%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net
Nonrelated Party
Related Party
Total accounts receivable, net
Other current assets
Total current assets
Deferred offering costs
Property and equipment, net
Right-of-use asset
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable, related party
Nonrelated Party
Related Party
Total accounts payable, related party
Accrued expenses
Deferred revenue
Current portion of operating lease liability, related party
Related Party
Total current portion of operating lease liability, related party
Notes payable
Revolving line of credit
Advances from related party
Total current liabilities
Non-current portion of operating lease liability, related party
Convertible notes payable
Total liabilities
Stockholders’ equity:
Common stock, value
Common Class A
Convertible Class B Common Stock
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments